Market Overview:
The global intrathecal drug market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of chronic pain, increasing geriatric population, and technological advancements in intrathecal drug delivery devices. However, the high cost of treatment and lack of reimbursement are some factors that are restraining the growth of this market. The global intrathecal drug market is segmented on the basis of type, application, and region. On the basis of type, it is divided into baclofen injection, ziconotide intrathecal infusion therapy (ZiNT), morphine injection therapy (MIT), and others (including local anesthetics). Baclofen injection dominates the global intrathecal drug market owing to its high usage for treating spasticity caused by various neurological disorders such as multiple sclerosis (MS) and cerebral palsy. ZiNT is expected to grow at a highest CAGR during forecast period due its benefits over traditional therapies for chronic pain management such as opioids or NSAIDs. MIT segment held largest share in 2017 due its widespread use for managing moderate-to-severe cancer pain refractory to oral morphine administration In terms on application; adult patients accounted for majority share in 2017 owing higher prevalence rate across globe followed by child & teen patients segments with fastest growing rate during forecast period 2018-2030 respectively .
Product Definition:
Intrathecal drug is a drug administered directly into the cerebrospinal fluid (CSF), which bathes the brain and spinal cord. Intrathecal drug therapy is used to treat pain, spasticity, and other conditions.
Baclofen Injection:
Baclofen is a muscle relaxant and sedative used for the treatment of spasticity related to multiple sclerosis, cerebral palsy, and stroke. Baclofen also has uses in the form of transdermal patches for treating severe chronic pain due to cancer or arthritis.
Ziconotide Intrathecal Infusion:
Ziconotide is an amino acid that acts as a precursor to a fluorescent dye used for imaging and therapy. It has been found to have potential use in the treatment of pain management, especially chronic back pain. Ziconotide has also shown promise in reducing cancer-related nausea and vomiting, which are key symptoms associated with cancer. However, ziconotide's current clinical use extends only to treating neuropathic pain; it does not have U.
Application Insights:
The adult segment held the largest share of 72.1% in 2017. Intrathecal injections are used for various conditions such as pain, urinary retention and constipation in adults. The growing geriatric population is one of the major drivers for intrathecal drug application in adults. For instance, according to a study published by NCBI, it was found that nearly 25% of the total population belongs to age group 60+ years which is a huge potential market for intrathecal drug application.
The child & teen segment held a significant share owing to increasing incidences of spina bifida and hydrocephalus which require treatment with intrathecal drugs at an early stage which were not available until now at low cost and high effectiveness but now everything will be changed with new innovative products under $ 200 per dose that can treat these diseases effectively without any side effects using only natural ingredients like botanicals.
Regional Analysis:
Asia Pacific region is anticipated to witness the fastest growth over the forecast period. The presence of a large patient pool and favorable government initiatives are some of the factors responsible for regional market growth. Increasing awareness regarding spinal cord injury treatment options, availability of highly skilled physicians, and high healthcare expenditure levels in countries such as China & India are expected to drive Intrathecal Drug Delivery Systems (IDDS) market demand during the forecast period.
North America held a significant share in 2016 owing to increasing R&D investments by pharmaceutical companies coupled with rising incidence rates due to falls & trauma accidents that result into spinal cord injuries.
Growth Factors:
- Increasing incidence of chronic pain: The Intrathecal Drug market is expected to grow at a CAGR of 5.5% during the forecast period owing to the increasing incidence of chronic pain. According to the American Academy of Pain Medicine, around 100 million Americans are living with chronic pain, which is more than those suffering from heart disease, cancer, and diabetes combined.
- Rising geriatric population: The global geriatric population is expected to reach 2 billion by 2050. This will lead to an increase in the number of patients suffering from age-related diseases such as arthritis and Alzheimer’s disease, which will drive demand for Intrathecal Drug products over the forecast period.
- Technological advancements: The development of novel drug delivery systems such as implantable pumps and microspheres has led to increased use of Intrathecal Drug products in recent years. These technological advancements are likely to spur growth in this market over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Intrathecal Drug Market Research Report
By Type
Baclofen Injection, Ziconotide Intrathecal Infusion, Morphine Injection
By Application
Adult, Child & Teen
By Companies
Medtronic, Jazz Pharmaceuticals, West Ward Pharmaceutical, Saol Therapeutics, Piramal Critical Care, Fresenius Kabi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Intrathecal Drug Market Report Segments:
The global Intrathecal Drug market is segmented on the basis of:
Types
Baclofen Injection, Ziconotide Intrathecal Infusion, Morphine Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Child & Teen
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Jazz Pharmaceuticals
- West Ward Pharmaceutical
- Saol Therapeutics
- Piramal Critical Care
- Fresenius Kabi
Highlights of The Intrathecal Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Baclofen Injection
- Ziconotide Intrathecal Infusion
- Morphine Injection
- By Application:
- Adult
- Child & Teen
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intrathecal Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intrathecal drug is a medication that is administered directly into the spinal cord through a catheter. Intrathecal drugs are used to treat conditions such as pain, spasticity, and tremors.
Some of the major players in the intrathecal drug market are Medtronic, Jazz Pharmaceuticals, West Ward Pharmaceutical, Saol Therapeutics, Piramal Critical Care, Fresenius Kabi.
The intrathecal drug market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Intrathecal Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Intrathecal Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Intrathecal Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Intrathecal Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Intrathecal Drug Market Size & Forecast, 2018-2028
4.5.1 Intrathecal Drug Market Size and Y-o-Y Growth
4.5.2 Intrathecal Drug Market Absolute $ Opportunity
Chapter 5 Global Intrathecal Drug Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Intrathecal Drug Market Size Forecast by Type
5.2.1 Baclofen Injection
5.2.2 Ziconotide Intrathecal Infusion
5.2.3 Morphine Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Intrathecal Drug Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Intrathecal Drug Market Size Forecast by Applications
6.2.1 Adult
6.2.2 Child & Teen
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Intrathecal Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Intrathecal Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Intrathecal Drug Analysis and Forecast
9.1 Introduction
9.2 North America Intrathecal Drug Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Intrathecal Drug Market Size Forecast by Type
9.6.1 Baclofen Injection
9.6.2 Ziconotide Intrathecal Infusion
9.6.3 Morphine Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Intrathecal Drug Market Size Forecast by Applications
9.10.1 Adult
9.10.2 Child & Teen
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Intrathecal Drug Analysis and Forecast
10.1 Introduction
10.2 Europe Intrathecal Drug Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Intrathecal Drug Market Size Forecast by Type
10.6.1 Baclofen Injection
10.6.2 Ziconotide Intrathecal Infusion
10.6.3 Morphine Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Intrathecal Drug Market Size Forecast by Applications
10.10.1 Adult
10.10.2 Child & Teen
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Intrathecal Drug Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Intrathecal Drug Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Intrathecal Drug Market Size Forecast by Type
11.6.1 Baclofen Injection
11.6.2 Ziconotide Intrathecal Infusion
11.6.3 Morphine Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Intrathecal Drug Market Size Forecast by Applications
11.10.1 Adult
11.10.2 Child & Teen
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Intrathecal Drug Analysis and Forecast
12.1 Introduction
12.2 Latin America Intrathecal Drug Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Intrathecal Drug Market Size Forecast by Type
12.6.1 Baclofen Injection
12.6.2 Ziconotide Intrathecal Infusion
12.6.3 Morphine Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Intrathecal Drug Market Size Forecast by Applications
12.10.1 Adult
12.10.2 Child & Teen
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Intrathecal Drug Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Intrathecal Drug Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Intrathecal Drug Market Size Forecast by Type
13.6.1 Baclofen Injection
13.6.2 Ziconotide Intrathecal Infusion
13.6.3 Morphine Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Intrathecal Drug Market Size Forecast by Applications
13.10.1 Adult
13.10.2 Child & Teen
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Intrathecal Drug Market: Competitive Dashboard
14.2 Global Intrathecal Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Jazz Pharmaceuticals
14.3.3 West Ward Pharmaceutical
14.3.4 Saol Therapeutics
14.3.5 Piramal Critical Care
14.3.6 Fresenius Kabi
